People · Operator

Enrique Poradosu

Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology, Pharmaceuticals

2
Companies
2
Filings
$27.2M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Nuvectis Pharma, Inc.—BiotechnologySeries B$15.9M$259.4M2022
Centry Pharma, Inc.—PharmaceuticalsSeries A$11.3M$234.3M2021
Operator network

Enrique Poradosu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Michael Carson · 1 companies · 1 sharedMichael CarsonRon Bentsur · 4 companies · 2 sharedRon BentsurKenneth Hoberman · 3 companies · 2 sharedKenneth HobermanMatthew Kaplan · 3 companies · 2 sharedMatthew KaplanJames Oliviero · 2 companies · 2 sharedJames OlivieroShay Shemesh · 2 companies · 2 sharedShay ShemeshUri Ben Or · 2 companies · 1 sharedUri Ben OrNuvectis Pharma, Inc. · $15.9M raisedNuvectis Pharma, Inc.Centry Pharma, Inc. · $11.3M raisedCentry Pharma, Inc.Enrique PoradosuEP
Enrique Poradosu Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Enrique Poradosu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Ron Bentsur24
Kenneth Hoberman23
Matthew Kaplan23
Shay Shemesh22
James Oliviero22
Uri Ben Or12
Michael Carson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.